FibroGen
FGEN
$1.04
Share price
1.96%
Change (1 day)
-93.93%
Change (1 year)
Categories
FibroGen (FGEN) - P/B ratio
P/B ratio as of April 2024 : -0.6333
According to FibroGen's latest financial reports the company has a price-to-book ratio of -0.6333.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
FibroGen - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.5374 | -99.95% |
| 2022-12-31 | < -1000 | -17925.33% |
| 2021-12-31 | 5.71 | -25.38% |
| 2020-12-31 | 7.65 | 8.9% |
| 2019-12-31 | 7.02 | -6.14% |
| 2018-12-31 | 7.48 | 5.18% |
| 2017-12-31 | 7.11 | -7.85% |
| 2016-12-31 | 7.72 | -19.56% |
| 2015-12-31 | 9.60 | 43.06% |
| 2014-12-31 | 6.71 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | 3.39 | -635.23% | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | -0.5752 | -9.18% | 🇺🇸 USA |